Trends in the lung cancer incidence and mortality in the Slovak and Czech Republics in the contexts of an international comparison
Jazyk angličtina Země Itálie Médium print-electronic
Typ dokumentu srovnávací studie, časopisecké články
- MeSH
- incidence MeSH
- kouření epidemiologie mortalita MeSH
- lidé MeSH
- lineární modely MeSH
- nádory plic epidemiologie mortalita MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- srovnávací studie MeSH
- Geografické názvy
- Česká republika epidemiologie MeSH
- Slovenská republika epidemiologie MeSH
INTRODUCTION: Lung cancer represents the most frequent cause of cancer-related deaths in the industrialized countries. The aim of this study was to analyze the lung cancer incidence and mortality and the possible reasons for any differences discovered in two neighboring Central European countries-the Slovak Republic. METHODS: We used linear regression model when analyzing incidence and mortality; the trends are presented with corresponding 95% confidence intervals (CI) and p-value with null hypothesis being constant with time. RESULTS: Statistically significant increase of age-standardized incidence (0.707/100,000/year, 95% CI 0.107-1.307, p = 0,025) and mortality (1.339/100,000/year, 95% CI 1.050-1.629, p < 0.0001) of the lung cancer was revealed in males in the Slovak Republic (1980-1991). On the contrary, values of both indicators were stabilized in the Czech Republic. Since year 1991-2005 a statistically highly significant decrease of both incidence and mortality values was observed in males, which was greater in the Slovak Republic. Peak of the curve was not reached in women population, while incidence and mortality values have significantly continuous growth in both countries. CONCLUSIONS: According to the lung cancer incidence and mortality trends in both countries (in correlation with smoking prevalence) we consider the support of efforts to change the attitude towards smoking predominantly in women and younger generation to be the most accurate action to reduce these trends.
Zobrazit více v PubMed
Int J Cancer. 2010 Mar 15;126(6):1454-66 PubMed
Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1688-94 PubMed
Eur J Clin Nutr. 1990 Mar;44(3):185-93 PubMed
Cent Eur J Public Health. 2009 Sep;17(3):115-21 PubMed
Prev Med. 2001 Mar;32(3):295-301 PubMed
J Epidemiol Community Health. 1994 Jun;48(3):220-3 PubMed
Int J Cancer. 2004 Apr 20;109(4):598-610 PubMed
Clin Chest Med. 1992 Jun;13(2):341-54 PubMed
BMJ. 1997 Oct 18;315(7114):980-8 PubMed
BMJ. 1996 Dec 7;313(7070):1450-3 PubMed
Food Chem Toxicol. 2003 Jun;41(6):807-17 PubMed
Eur J Cancer. 2004 Jan;40(1):96-125 PubMed
Cancer Causes Control. 2002 Mar;13(2):175-82 PubMed
Neoplasma. 2004;51(2):136-43 PubMed
Stat Methods Med Res. 1998 Jun;7(2):119-36 PubMed
IARC Monogr Eval Carcinog Risks Hum. 2004;83:1-1438 PubMed
Am J Epidemiol. 2005 Mar 1;161(5):412-22 PubMed
Chest. 2007 Sep;132(3 Suppl):29S-55S PubMed
